Brain Cleaning of Sleep Achieved During Wake, Suggest Studies of Emerging At-Home Technology
A noninvasive treatment may safely stimulate brain toxin clearance via meningeal lymphatic vessels during wakefulness.
A noninvasive treatment may safely stimulate brain toxin clearance via meningeal lymphatic vessels during wakefulness.
The investment by a new US-based healthcare investor strengthens the balance sheet and reinforces US focus, the company says.
The funding will support clinical testing of NovaResp's cMAP software, which aims to provide personalized, low-pressure CPAP therapy for better patient adherence and outcomes.
NeuroLight Inc developed a prototype of a sleep mask that uses light and sound for brain entrainment to improve sleep quality.
Read MoreThe FDA has agreed on the design for Nexalin’s planned clinical studies of the Gen-3 HALO Clarity, targeting insomnia and anxiety.
Read MoreNyxoah advances its US launch plans for the Genio system, which recently achieved positive co-primary endpoints in the DREAM US pivotal study.
Read MoreThe company is now boosting production to 500 units in anticipation of US clinical trials aimed at validating the device’s efficacy for at-home insomnia treatment.
Read MoreAlkermes plc announced positive results from a phase 1b study evaluating ALKS 2680 for treating narcolepsy type 2 and idiopathic hypersomnia.
Read MoreResearch involving 67 subjects who participated in over 7,772 sleep sessions demonstrated that 73% experienced notable improvements in their sleep, with enhancements in the depth and overall quality of sleep noted.
Read MoreResearchers tested technology that allows people to control a smart home from lucid dreams. As a result, these people completed some typical morning actions before even waking up.
Read MoreThe platform uses neurotechnology to read individual brainwaves and guide them in real time by responding with tailored stimulation.
Read MoreThe patent covers a novel method of facilitating a normal sleep cycle in a subject during a pandemic or peri-COVID vaccination period.
Read MoreA study demonstrated improvements in deep sleep using the Soltec System, which consists of a non-invasive magnetic generator placed under the bed or near the footboard.
Read MoreNyxoah’s CEO says the company is on the cusp of “the most significant milestone” in its history.
Read MoreResearchers have developed an ingestible capsule to non-invasively diagnose sleep apnea by monitoring vital signs from within the gastrointestinal tract.
Read MoreResearchers have developed miniaturized wearable devices that continuously and wirelessly monitor sounds inside patients’ bodies, which could offer a new tool for detecting and analyzing apneas in premature infants.
Read MoreA Dongguan, China-based sleep technology brand launched a new smart sleep line of artificial intelligence (AI)-powered mattresses, pillows, and beds.
Read MoreNyxoah SA has partnered with ResMed Germany to increase OSA awareness and therapy penetration in the German market.
Read More